Drug Profile
CIGB 550 E7
Alternative Names: Human papillomavirus vaccine - Heber BiotecLatest Information Update: 30 Aug 2023
Price :
$50
*
At a glance
- Originator Center for Genetic Engineering and Biotechnology
- Developer Center for Genetic Engineering and Biotechnology; Heber Biotec
- Class Antineoplastics; Cancer vaccines; Immunotherapies; Peptide vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cervical cancer
Most Recent Events
- 30 Aug 2023 Discontinued - Preclinical for Cervical cancer in Cuba (SC)
- 28 Mar 2020 No recent reports of development identified for preclinical development in Cervical-cancer in Cuba (SC, Injection)
- 23 Feb 2016 Preclinical trials in Cervical cancer in Cuba (SC) prior to February 2016